|Publication number||USRE43174 E1|
|Application number||US 11/655,039|
|Publication date||Feb 14, 2012|
|Filing date||Jan 18, 2007|
|Priority date||Apr 11, 2000|
|Also published as||CA2406185A1, CA2406185C, CA2733850A1, CA2733850C, CA2826724A1, DE60114393D1, DE60114393T2, EP1272243A2, EP1272243B1, US6557549, US6848443, US20020029779, US20030226562, USRE45068, WO2001076671A2, WO2001076671A3|
|Publication number||11655039, 655039, US RE43174 E1, US RE43174E1, US-E1-RE43174, USRE43174 E1, USRE43174E1|
|Inventors||James N. Schmidt, Daniel Engelbreth, Rick Blacker|
|Original Assignee||Trudell Medical International|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (102), Non-Patent Citations (26), Referenced by (2), Classifications (19), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation of U.S. application Ser. No. 09/833,019, filed Apr. 11, 2001, now U.S. Pat. No. 6,557,549, which claims the benefit of U.S. Provisional Application No. 60/196,555, filed Apr. 11, 2000, wherein the entirety of each of the aforementioned applications are incorporated herein by reference.
The invention relates to an apparatus and method for performing Positive Expiratory Pressure (PEP) therapy. More particularly, this invention relates to a method and apparatus for performing PEP therapy alone or in conjunction with an aerosol delivery apparatus.
PEP therapy is used primarily in pulmonary secretion removal. Devices used to perform PEP therapy provide positive pressure during expiration. The patient or user exhales against a fixed orifice resistor and generates a pressure ranging approximately from 10-20 cm H2O. The resistance orifice is an important consideration and frequently is initially set by a physician, veterinarian, or a skilled practitioner in the art. An orifice that is too large may result in a short exhalation that will not produce proper expiratory pressure. An orifice that is too small may result in a longer expiratory phase that raises the pressure above approximately 20 cm H2O and ultimately increases the work of breathing.
During the exhalation phase of PEP therapy, the airway is splinted open by the pressure. This causes the movement of secretions from the peripheral airways into the larger airways where they can be expelled. PEP therapy usually lasts for about 10-20 minutes and is performed as required, generally 1-4 times per day. Typically, the patient performs 10-20 PEP breaths, removes the device from their mouth and follows this with a forceful exhalation. This final exhalation triggers a cough that loosens secretions.
Studies indicate that PEP therapy dilates the airways and improves the distribution of ventilation, resulting in a better deposition of an inhaled substance, such as, but not limited to, a medicine or remedy. As used herein, the term “aerosol delivery apparatus” means any apparatus capable of producing and/or delivering a substance, such as, but not limited to, a medicine, in a form suitable for inhalation by a patient and includes, without limitation, an aerosol holding chamber, nebulizer, spacer with integrated actuator, a dry powder inhaler, and a metered dose inhaler.
One aspect of the present invention is directed to a positive respiratory pressure apparatus including a patient respiratory system interface and a valve assembly in fluid communication with the patient respiratory system interface. The valve assembly has a valve configured to pass a fluid traveling in a predetermined direction from a first side to a second side of the valve, and a variable resistance bypass window positioned adjacent the valve and having a resistance to a fluid traveling in a direction opposed to the predetermined direction, where the variable resistance bypass window is continuously adjustable between a first fluid resistance and a second fluid resistance.
According to another aspect of the invention an apparatus is disclosed that is capable of performing positive expiratory pressure (PEP) therapy alone or in combination with providing a substance, generally in aerosol form. The apparatus includes a positive pressure (PP) valve having a continuously variable respiratory window. As used herein, the term respiratory is intended to encompass both inhalation and exhalation. Whether inhalation resistance or exhalation resistance is called for will be known to one skilled in the art. The valve may be located at or near the output end of an aerosol delivery apparatus. U.S. application Ser. No. 08/938,686 filed Sep. 26, 1997 in the name of Engelbreth et al. and Ser. No. 09/287,997 filed on Apr. 7, 1999 in the name of Schmidt et al. describe exemplary embodiments of an aerosol delivery apparatus and the disclosures of these references are incorporated herein by reference. Further, U.S. Pat. No. 4,470,412 to Nowacki et al., describing a spacer or expansion chamber, is additionally incorporated herein by reference. The aerosol delivery apparatus with the PP apparatus may be used alone or in combination with a mask or mouthpiece.
In one embodiment, the PP apparatus is associated with a mask. The mask with the PP apparatus may be used alone or in combination with an aerosol delivery apparatus. In another embodiment, the PP apparatus is associated with a mouthpiece. The mouthpiece with the PP apparatus may be used alone or in combination with an aerosol delivery apparatus. In a further embodiment, the PP apparatus is associated with a nebulizer. The nebulizer with the PP apparatus may be used alone or in combination with a patient respiratory system interface, such as a mask or mouthpiece. In yet another embodiment, the PP apparatus is associated with a spacer chamber with an integrated actuator. The spacer chamber with the integrated actuator associated with the PP apparatus may be used alone or in combination with a mouthpiece or mask.
In another embodiment, a pressurized metered dose inhaler canister is capable of association with an aerosol holding chamber having a PP valve associated therewith. In yet a further embodiment, a pressurized metered dose inhaler canister is capable of association with an aerosol holding chamber engageable with a mouthpiece or mask having a PP valve associated therewith.
Another aspect of the invention is directed to a kit for performing positive expiratory pressure including an aerosol delivery apparatus, a mouthpiece and/or mask attachable to the output end of the aerosol delivery apparatus, and a PP apparatus. The PP apparatus may be located on the aerosol delivery apparatus or the mouthpiece and/or mask. In alter- native embodiments, the PP apparatus may be attached to the aerosol delivery apparatus or integrally formed with the apparatus. The aerosol delivery apparatus, mouthpiece, and PP valve can be combined so as to accomplish positive expiratory therapy and administration of a substance, such as, but not limited to, a medicine in aerosol form. Any aerosol delivery apparatus may be used. In further embodiments of the kit, a backpiece is included for association with an aerosol delivery apparatus. A pressurized metered dose inhaler can engage with the backpiece for delivery of a medicament.
One embodiment of a method of performing positive expiratory pressure therapy includes providing a PP apparatus with a valve that is capable of providing a continuously variable expiratory window. The method further includes performing a series of breaths. When exhalation is performed, the exhalant is directed through the continuously variable expiratory window. Performance of a therapeutic cough triggers the loosening of secretions. Upon loosening of the secretions, a substance, such as a medicament, may be provided for inhalation into the respiratory system. In an alternative embodiment of method, the PP valve may be positioned so as to provide positive inspiratory pressure upon inhalation into the apparatus.
A further aspect of another embodiment includes association of a PP apparatus associable with a mask or mouthpiece engageable with a backpiece device. The backpiece device includes a plastic or an elastomeric adapter suited to receive the mouthpiece of a pressurized metered dose inhaler.
One embodiment of a method of performing positive expiratory pressure therapy includes providing a positive expiratory pressure apparatus having a valve capable of providing a continuously variable resistance window, performing a series of breaths including inhalation and exhalation; exhaling so that the exhalant is directed through the continuously variable resistance window, performing a therapeutic cough triggering the loosening of secretions, and providing an inhaleable medicament.
Another embodiment of a method of performing positive expiratory pressure therapy includes providing a positive respiratory pressure apparatus having a valve capable of providing a continuously adjustable resistance to exhalation, where the valve is located in a mouthpiece attachable to a chamber. A patient then executes a series of therapeutic breaths, including inhalation and exhalation, wherein the exhalant is directed through the continuously adjustable resistance window, the patient performs a therapeutic cough triggering the loosening of secretions, and medicament is provided via the chamber.
According to another aspect of the invention, a method of performing positive expiratory pressure therapy in combination with providing an aerosolized medicament includes providing a positive expiratory pressure apparatus having a positive expiratory pressure valve capable of providing a continuously variable resistance window, where the valve is positionable in a mouthpiece and the mouthpiece attachable to an aerosol holding chamber. A series of therapeutic breaths, including inhalation and exhalation, are then taken where the exhalant is directed through the continuously variable resistance window. The continuously variable resistance window is preferably capable of providing a variable back pressure to the exhalant. A therapeutic cough capable of triggering the loosening of sections is performed and aerosolized medicament from the aerosol holding chamber is administered through inhalation.
One embodiment of an apparatus capable of performing positive respiratory pressure therapy in combination with providing an aerosolized medicament includes a positive respiratory pressure valve having a continuously variable resistance window; and an aerosol holding chamber having an output end, the positive respiratory pressure valve locatable at the output end.
Another embodiment of an apparatus capable of performing positive respiratory pressure therapy includes a positive respiratory pressure valve having a slide control, the slide control providing a continuously variable resistance window; and a mouthpiece, the mouthpiece having a first and a second end, the second end capable of association with the positive respiratory pressure valve.
Yet another embodiment of an apparatus capable of performing positive respiratory pressure therapy in combination with providing an aerosolized medicament includes a positive respiratory pressure valve having a continuously variable resistance window; an aerosol holding chamber having an input end and an output end, the positive respiratory pressure valve locatable at the output end; and a metered dose inhaler canister capable of association with the input end of the aerosol holding chamber.
A still further embodiment of a kit for performing positive expiratory pressure includes an aerosol holding chamber having an inlet and an outlet. A backpiece is attachable to the inlet of the aerosol holding chamber with a metered dose inhaler capable of association with the backpiece. A mouthpiece is attachable to the outlet of the aerosol holding chamber. A positive expiratory pressure valve is generally locatable at the outlet end of the aerosol holding chamber, wherein the aerosol holding chamber, backpiece, mouthpiece, and positive expiratory pressure valve can be combined so as to accomplish positive expiratory therapy and administration of an aerosolized medicament.
An additional embodiment of an apparatus capable of performing positive expiratory pressure therapy in combination with providing an aerosolized medicament includes a positive expiratory pressure valve having a continuously variable resistance window, a mouthpiece, the positive expiratory pressure valve associable with the mouthpiece, and a nebulizer having an input end and an output end, the positive expiratory pressure valve associable with the output end.
Further embodiments include a mouthpiece wherein the improvement comprises a positive pressure valve. An additional embodiment includes a nebulizer wherein the improvement comprises a positive pressure valve. Moreover, an embodiment includes an aerosol holding chamber wherein the improvement comprises a positive pressure valve. A yet further embodiment includes a pressurized metered dose inhaler wherein the improvement comprises a positive pressure valve.
The invention will best be understood by reference to the following detailed description of the preferred embodiment, taken in conjunction with the accompanying drawings. The discussion below is descriptive, illustrative and exemplary and is not to be taken as limiting the scope defined by any appended claims.
In the embodiment of
In the embodiment depicted in
The PP valve 12 may be located on or in conjunction with a mouthpiece 16. An exemplary embodiment of the mouthpiece 16 shown in
Generally, in one exemplary embodiment, the PP valve 12 may be located at or near the distal end 30 of the mouthpiece 16. Although, it is understood that the PP valve 12 may be located anywhere on the mouthpiece 1 and its location is not to be limited. In an alternative embodiment, the PP valve 12 may be located at or near the output end 20 of the aerosol delivery apparatus, such as, but not limited to, the aerosol holding chamber 14 of
In a preferred embodiment the mouthpiece 16 is formed of plastic. The plastic may be either rigid or soft. Other materials that can also be used for the mouthpiece 16 include metal or other materials known to one in the art. In the embodiment depicted in
In a further embodiment, as shown in
In the illustrated embodiment, the tab setting 46 is a uniformly molded projection from the slide control 26. In a preferred embodiment, the tab setting 46 has smooth edges for easy engagement with the finger, thumb or appendix of the user. The tab setting 46 may also have a serrated edge or any other edge known in the art. When assembled with the mouthpiece 16, the tab setting 46 projects through the mouthpiece from the tab window 48. The user of the device manipulates the tab setting 46 in such a manner as to cause, either directly or indirectly, the movement of the slide control 26 thereby varying the opening of the resistance window 28.
In the embodiment of
In the embodiment shown in
The end of the slide control 26 opposite the control arm 56 may either be provided with a finger projection 58 or may be smooth. The length of the slide control 26 extending from the tab setting 46 to the end of the control arm 56 opposite the projection 58 is generally the length of the resistance window 28. This resistance control length 60 is at least the length that the resistance window 28 can be opened allowing for exhalant to exit the window 28. In a preferred embodiment, the slide control 26 is manufactured of a plastic. The plastic may be either rigid or soft. Other materials that can also be used for the slide control 26 include metal or other materials known in the art.
In general, as shown in
An alternative embodiment of an assembly 100 for performing PEP therapy is shown in
The detent 158 located on the tab setting 146 is associated with at least one detent notch 154 as shown in
The slide control 126, as shown in
As described above, and similar to the embodiment of
The mouthpiece assembly 216 is connected to the output end 222 of the chamber housing 214 by placing the apertures 284 over the locking tabs 281. As with the embodiment of
A valve 278 having a valve member 279 and a valve seat 280 is shown. The valve seat 280 preferably comprises the rim of the valve and the corresponding raised lip 283 on the outlet end 222 of the chamber housing 214. The valve member has a sealing surface that preferably forms between two parallel portions, or lips, of the valve. In a preferred embodiment, the valve material seals against itself when fluid flows against a predetermined flow direction of the valve. In the embodiment shown, the valve is a duck-bill valve where the valve seat 280 is positioned axially away from the valve opening. The valve 278 defines a central open area toward the end having the valve seat. The valve member 279, shown as parallel sealing lips in
In one preferred embodiment, the duck-bill valve 278 has a central open area 274 at its base that has a diameter of approximately 26.09 millimeters (mm). The width of the lips that form the valve member 279 is approximately 21.35 mm and the angle at which the walls 285 converge is approximately 72 degrees. Also, the height of the duck-bill valve 278 measured from the upper portion 282 of the valve seat to the valve member 279 is approximately 18.8 mm. The mouthpiece 216 for containing this valve 278 preferably includes a resistance widow gap 225 having a length of 59 degrees of arcuate cut in the annular sealing ring 224, where the annular sealing ring is approximately 31.4 mm in diameter and has a height of 4.5 mm.
The operation of the apparatus will now be discussed generally with reference to the embodiments of
Exhalation by the patient results in air traveling through the mouthpiece in a direction opposite the predetermined inhalation flow path of the valve. This air, which is blocked from passage through the valve along the inhalation path, then passes along a second path through the resistance window in the mouthpiece. Also, the force of the exhaled air causes the outer portion of the valve to move away from the mouthpiece in a direction towards the chamber housing. As a result, an exhalation pathway is created between the outer portion of the valve and the mouthpiece through which the exhaled air passes out to the atmosphere or some other predetermined location. As described above, the amount of effort that exhalation requires is set by the slide control, which may be set to block the appropriate amount of the resistance window to achieve the desired resistance.
Referring specifically to the duck-bill valve embodiment of
As shown in
Although the embodiments of
Referring again to
Upon exhalation into the proximal end 430 of the mouthpiece 416, a positive pressure builds in the nebulizer 414 and the piston acts as a one-way valve to close off the flow of air out of the nebulizer. Now, the exhalant must travel through the one-way valve in the PP valve assembly 412, through the slide control and out the resistance window. Preferably the slide control 426 under the resistance window 428 has been set to the appropriate position for the patient so that effective PEP therapy may be provided. Although the PEP apparatus of
Although positive expiratory devices have been shown in detail, embodiments of positive inspiratory devices are also contemplated.
As discussed above, embodiments of patient respiratory system interfaces aside from the mouthpiece configurations already disclosed are contemplated. A PP apparatus 510 utilizing a mask 512 as the interface is illustrated in
This embodiment depicts the resistance window 528 as a curved tear-drop like shape. The platform 526 is shown as a circular disc having at least one port opening 530. The port opening 530 may vary in size and shape. The opening formed for the exhalant to pass through is related to the alignment of the resistance window 528 with the port opening 530. In this embodiment, the resistance window is moveably mounted relative to a fixed slide control portion attached to the mask. Tabs 542 on the platform 526 preferably mate with tab receiving regions 544 on the end of the nosepiece section 516 to retain the platform in a fixed position relative to the mask. Moving the tear-drop shaped resistance window 528 past the part opening 530 vanes the exhalant path. In other embodiments, a plurality of resistance window openings 528 may be moved past the port 530. Alternatively, there may be a plurality of ports in the slide control 526.
As shown in
In alternative embodiments, PEP therapy maybe performed with a mouthpiece or mask having the PP valve associated with a backpiece. The mask or mouthpiece may have an extended inlet for association with the backpiece.
Asthmatic medications are commonly supplied in metered dose inhalers, frequently referred to as pressurized metered dose inhalers. Pressurized metered dose inhalers are generally cylindrical canisters with axially extending vent tubes from internal valves. When the external tube or stem of a pressurized metered dose inhaler canister is depressed it operates the internal valve to dispense a measured dose of medicine from the stem. The medicine is commonly packed in the canister with a suitable compressed gas to propel the medicine and gas from the stem or tube when the later is depressed. The medicine may be in gas, liquid, or solid form. The manufacturer or distributor of the pressurized metered dose inhaler canister generally supplies it with a substantially L-shaped adapter which receives the canister in a substantially upright position, and has a substantial horizontal outlet portion for reception in the mouth of an asthmatic patient for inhalation of the medicine.
In order to address the problem of coordination and other problems known in the art with regard to pressurized metered dose inhalers, a spacer chamber with an integrated actuator, or an aerosol holding chamber, have been used in attempts to overcome inappropriate particle size. The aerosol holding chamber is generally provided at the upstream or entering end with a flexible, resilient adapter or backpiece made of rubber or the like material. A central aperture is provided for receipt of the horizontal outlet portion of the pressurized metered dose inhaler adapter.
One embodiment provides for an improved pressurized metered dose inhaler or pressurized metered dose inhaler with an aerosol holding chamber. As shown in
Generally, a mouthpiece or mask may be associated the PP apparatus. In one configuration, an aerosol holding chamber may be attached to the mouthpiece or mask end and a metered dose inhaler may be positioned on a generally opposite end of the chamber via a backpiece. The user of the device may insert the mouthpiece into the mouth to obtain a dose of medicament. Further, the user may place the mask over the mouth and/or nose to inspire a dose of the medicament. In either situation, the mask or mouthpiece aids in the delivery of the medicament to the user.
As has been described, a method and apparatus from providing positive expiration or inhalation therapy, with or without separate aerosol generating devices, has been disclosed. In the embodiment where the positive expiratory pressure valve is located at or near the output end of the aerosol delivery apparatus, a one way inhalation valve can be located further downstream from the positive expiratory pressure valve. A mouthpiece and or mask can be affixed at or near the output end of the aerosol delivery apparatus. The positioning of the inhalation valve either upstream or downstream in respect to the positive expiratory pressure valve is well known to one skilled in the art. Further, it is envisioned that PEP therapy may be performed nasally with the positive expiratory pressure apparatus.
When the mouthpiece having the PP apparatus associated therewith is used alone to perform PEP therapy, and not in conjunction with a mechanism for the delivery of a substance, a one way inhalation valve is engageable with the mouthpiece. The inhalation valve functions so as to allow for inhalation by the patient into the mouthpiece. The exhalant of the patient is prevented from exiting via the inhalation valve and is directed to exit through the PP valve. Generally, an inhalation valve opens upon inhalation to allow a fluid, such as an aerosol, to enter a chamber or channel or the like but that closes upon exhalation to prevent exhaled fluids to enter into the chamber of the like. The drawings depict an exemplary embodiment of the one-way inhalation valve but are not to be limiting to the embodiments shown.
One aspect of the method of use of the PP apparatus can be understood by the following disclosure and reference to
The method of performing PEP therapy using the PP apparatus includes performing a series of breaths. When exhalation is performed, the exhalant is directed through the continuously variable expiratory window. Performance of a therapeutic cough triggers the loosening of secretions. Upon loosening of the secretions, a medicament may be provided for inhalation into the respiratory system. In one embodiment of PEP therapy, the user will exhale into the mouthpiece and/or mask, against the desired resistance. This is done either prior to or in combination with inhalation of the medicament. The exhaled gases exit through the resistance window. This process may be repeated as many times as prescribed by the patient's physician.
As has been described, a method and apparatus for providing positive expiration, or inhalation, pressure therapy, with or without separate aerosol generating devices, has been disclosed. The aerosol delivery apparatus with the PP apparatus may be used alone or in combination with a mask or mouthpiece. Also, an improved aerosol delivery apparatus with an integrated actuator has been shown, wherein the improvement comprises a PP valve. The discussion above is descriptive, illustrative and exemplary and is not to be taken as limiting the scope defined by any appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US393869||Sep 13, 1888||Dec 4, 1888||Inhaler|
|US2670739||Jul 2, 1951||Mar 2, 1954||Mcneill Charles M||Inhaler|
|US3236458||Feb 14, 1963||Feb 22, 1966||Ramis Jean||Aerosol apparatus|
|US3556122||Mar 26, 1969||Jan 19, 1971||Laerdal A S||Valve for artificial respiration apparatus|
|US3565071||Sep 19, 1968||Feb 23, 1971||Abbott Lab||Self-regulating therapeutic inhaler|
|US3643686||Oct 21, 1970||Feb 22, 1972||Koegel Ewald||High-velocity breathing valve|
|US3809084||Feb 8, 1972||May 7, 1974||American Cyanamid Co||Pressurized portable dispenser|
|US3809294||Jun 27, 1973||May 7, 1974||American Cyanamid Co||Dispensing lung contacting powdered medicaments|
|US3838686||Oct 14, 1971||Oct 1, 1974||G Szekely||Aerosol apparatus for inhalation therapy|
|US3897779||Jun 27, 1973||Aug 5, 1975||American Cyanamid Co||Triamcinolone acetonide inhalation therapy|
|US3994421||Sep 29, 1975||Nov 30, 1976||American Cyanamid Company||Unitary therapeutic aerosol dispenser|
|US4174712||Nov 7, 1977||Nov 20, 1979||Aktiebolaget Draco||Device for use with medicinal inhalation devices|
|US4182366||Jan 8, 1976||Jan 8, 1980||Boehringer John R||Positive end expiratory pressure device|
|US4198969||Jan 4, 1979||Apr 22, 1980||Baxter Travenol Laboratories, Inc.||Suction-operated nebulizer|
|US4231375||Oct 20, 1977||Nov 4, 1980||Boehringer John R||Pulmonary exerciser|
|US4267832||Apr 17, 1979||May 19, 1981||Haekkinen Taisto||Expiration valve apparatus for use with a respirator or like apparatus|
|US4275722||May 4, 1979||Jun 30, 1981||Sorensen Harry D||Respiratory exerciser and rebreathing device|
|US4292966||Feb 5, 1980||Oct 6, 1981||Aktiebolaget Draco||Aerosol inhalation device|
|US4298023||Sep 9, 1980||Nov 3, 1981||Mcginnis Gerald E||Spring loaded exhalation valve|
|US4344573||Jun 6, 1980||Aug 17, 1982||Hoechst Aktiengesellschaft||Spray applicator|
|US4470412||Mar 19, 1982||Sep 11, 1984||Trutek Research, Inc.||Inhalation valve|
|US4496086||May 5, 1982||Jan 29, 1985||Pari-Symac||Devices which comprise a helical spring used as conveying, extracting, quantity-controlling or mixing means|
|US4509515||Feb 7, 1983||Apr 9, 1985||Fisons Plc||Inhalation device|
|US4635631||Oct 29, 1984||Jan 13, 1987||Sharp Kabushiki Kaisha||Artificial respiration ventilator of air constant flow|
|US4637528||Jan 19, 1984||Jan 20, 1987||William H. Rorer, Inc.||Articulated joint in aerosol medicament dispenser|
|US4641644||Sep 5, 1985||Feb 10, 1987||Aktiebolaget Draco||Aerosol inhalation device|
|US4646644||Apr 9, 1984||Mar 3, 1987||Sanders Associates, Inc.||Pneumatic time delay valve|
|US4770413||Apr 27, 1987||Sep 13, 1988||Mba Healthcare Products, Inc.||Breathing exercise device|
|US4796614||Feb 26, 1987||Jan 10, 1989||Trutek Research, Inc.||Collapsible inhalation valve|
|US4846168||Dec 1, 1987||Jul 11, 1989||Mect Corporation||Inhaler|
|US4852561||Jul 27, 1988||Aug 1, 1989||Sperry C R||Inhalation device|
|US4886057||Nov 30, 1987||Dec 12, 1989||E Z Breathe, Inc.||Assisted breathing interface device|
|US4907583||Dec 16, 1988||Mar 13, 1990||Aktiebolaget Draco||Device in powder inhalators|
|US4940051||Dec 21, 1984||Jul 10, 1990||Huhtamki Oy||Inhalation device|
|US4981295||May 11, 1987||Jan 1, 1991||City Of Hope||Respiratory training using feedback|
|US5012803||Mar 6, 1989||May 7, 1991||Trudell Medical||Modular medication inhaler|
|US5012804||May 23, 1990||May 7, 1991||Trudell Medical||Medication inhaler with adult mask|
|US5033463||Oct 22, 1990||Jul 23, 1991||Miat S.P.A.||Multi-dose inhaler for medicaments in powder form|
|US5040527||Dec 18, 1990||Aug 20, 1991||Healthscan Products Inc.||Metered dose inhalation unit with slide means|
|US5042467||Sep 4, 1990||Aug 27, 1991||Trudell Medical||Medication inhaler with fitting having a sonic signalling device|
|US5048729||Jul 10, 1990||Sep 17, 1991||United Kingdom Atomic Energy Authority||Aerosol dispenser with flow diverter|
|US5109840||Feb 14, 1991||May 5, 1992||Specialty Packaging Licensing Company||Resuscitator having directional control valve with internal "PEEP" adjustment valve|
|US5178138||Sep 11, 1990||Jan 12, 1993||Walstrom Dennis R||Drug delivery device|
|US5193529||Aug 3, 1990||Mar 16, 1993||Emmanuel Labaere||Applicance for use in inspiration and expiration techniques and exercises|
|US5241954||May 24, 1991||Sep 7, 1993||Glenn Joseph G||Nebulizer|
|US5250287||May 11, 1992||Oct 5, 1993||Miat S.P.A.||Multi-dose insufflator for medicaments in powder form|
|US5280784||Nov 5, 1992||Jan 25, 1994||Paul Ritzau Pari-Werk Gmbh||Device in particular and inhalating device for treating the lung and the respiratory tracts|
|US5297543||Jun 24, 1992||Mar 29, 1994||Healthscan Products, Inc.||Medication inhaler mixer|
|US5309900||Oct 9, 1991||May 10, 1994||Paul Ritzau Pari-Werk Gmbh||Atomizer particularly for use in devices for inhalation therapy|
|US5312046||Sep 22, 1992||May 17, 1994||Paul Ritzau Pari Werk Gmbh||Liquid atomizer|
|US5357951||Jun 2, 1993||Oct 25, 1994||Mercury Enterprises, Inc||Cardiac pulmonary resuscitator apparatus valve with integral air sampling port|
|US5385140||Oct 6, 1993||Jan 31, 1995||Lindrew Pty Limited||Aerosol inhalation device|
|US5427089||Sep 8, 1993||Jun 27, 1995||Glaxo Group Limited||Valved auxiliary device for use with aerosol container|
|US5456249||Jan 5, 1994||Oct 10, 1995||Kirk; Gilbert M.||Resuscitator with carbon dioxide detector|
|US5458136||Mar 31, 1994||Oct 17, 1995||Paul Ritzau Pari-Werk Gmbh||Assembly for producing aerosol pulses|
|US5461695||Jul 27, 1993||Oct 24, 1995||Paul Ritzau Pari-Werk Gmbh||Nebulizing assembly with heating equipment|
|US5477849||May 31, 1994||Dec 26, 1995||Fry; Stephen||Spacer for medication inhaler|
|US5479920||Mar 1, 1994||Jan 2, 1996||Vortran Medical Technology, Inc.||Breath actuated medicinal aerosol delivery apparatus|
|US5497765||Jan 24, 1995||Mar 12, 1996||Rd-Chus Inc.||Device for the simultaneous delivery of beta-2 agonists and oxygen to a patient|
|US5497872||Jul 1, 1994||Mar 12, 1996||Pari Industries||Method and apparatus for cleaning conveyor belts|
|US5501214||Sep 26, 1994||Mar 26, 1996||Respironics, Inc.||Non-rebreathing valve and valve element therefor|
|US5505194||Oct 4, 1994||Apr 9, 1996||Abbott Laboratories||Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions|
|US5549102||Nov 1, 1994||Aug 27, 1996||Paul Ritzau Pari-Werk Gmbh||Nebulizer, especially for application in devices for inhalation therapy|
|US5562093||Sep 6, 1995||Oct 8, 1996||Gerson; Howard J.||Mouth-to-mouth resuscitation barrier|
|US5575282||Nov 1, 1994||Nov 19, 1996||Paul Ritzau Pari-Werk Gmbh||Oxygen distributor with both mouth and nose delivery ports|
|US5596982||May 17, 1995||Jan 28, 1997||Paul Ritzau Pari-Werk Gmbh||Apparatus for drying and buffering aerosols|
|US5598839||Apr 20, 1994||Feb 4, 1997||Diemolding Corporation||Positive expiratory pressure device|
|US5617844||Sep 21, 1995||Apr 8, 1997||King; Russell W.||Aerosol medication delivery system|
|US5629032||May 28, 1996||May 13, 1997||Pari Industries, Inc.||Blow-molding apparatus|
|US5645049||Jul 5, 1994||Jul 8, 1997||Trudell Medical Limited||Exhalation valve for face mask with spacer chamber connection|
|US5647345||Jun 7, 1995||Jul 15, 1997||Saul; Gilbert D.||Respiratory stimulator & methods of use|
|US5657853||Jan 13, 1995||Aug 19, 1997||Pari Industries, Inc.||Belt conveyors having cleaning rollers|
|US5658221||Jun 7, 1995||Aug 19, 1997||Hougen; Everett D.||Portable personal breathing apparatus and method of using same|
|US5676130||Mar 18, 1996||Oct 14, 1997||Boehringer Ingelheim Gmbh, Inc.||Separator for powdered inhalers|
|US5724959||Sep 16, 1994||Mar 10, 1998||Aea Technology Plc||Powder inhaler with specific orifice and baffle arrangement|
|US5724962||Oct 14, 1993||Mar 10, 1998||Orion-Yhtyma Oy||Valve for use in connection with an inhaler apparatus|
|US5738087||Dec 13, 1996||Apr 14, 1998||King; Russell W.||Aerosol medication delivery system|
|US5740966||Dec 6, 1996||Apr 21, 1998||Paul Ritzau Pari-Werk Gmbh||Nebulizer nozzle|
|US5755221||Oct 24, 1994||May 26, 1998||Bisgaard; Hans||Aerosol inhaler with piston dump|
|US5765553||Nov 27, 1996||Jun 16, 1998||Diemolding Corporation||Aerosol medication delivery facemask adapter|
|US5775320||Dec 22, 1995||Jul 7, 1998||Inhale Therapeutic Systems||Method and device for delivering aerosolized medicaments|
|US5816240||Mar 13, 1997||Oct 6, 1998||Techbase Pty. Ltd.||Spacer|
|US5840279||Jun 21, 1996||Nov 24, 1998||Asta Medica Aktiengesellschaft||Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments|
|US5848588||Oct 17, 1996||Dec 15, 1998||Trudell Medical Group||Backpiece for receiving an MDI adapter in an aerosolization spacer|
|US5881718||Mar 24, 1995||Mar 16, 1999||Astra Aktiebolag||Valve|
|US5890998||Jan 30, 1998||Apr 6, 1999||Hougen; Everett Douglas||Portable personal breathing apparatus|
|US5896857||Dec 20, 1996||Apr 27, 1999||Resmed Limited||Valve for use in a gas delivery system|
|US5899832||Jun 13, 1997||May 4, 1999||Hougen; Everett D.||Compact lung exercising device|
|US5925831||Oct 14, 1998||Jul 20, 1999||Cardiopulmonary Technologies, Inc.||Respiratory air flow sensor|
|US5957389||Jan 21, 1997||Sep 28, 1999||Paul Ritzau Pari-Werk Gmbh||Nebuliser|
|US6000394||Aug 25, 1997||Dec 14, 1999||Paul Rizau Pari-Werk Gmbh||Generation of an aerosol of an exact dose|
|US6026807||Feb 27, 1998||Feb 22, 2000||Diemolding Corporation||Metered dose inhaler cloud chamber|
|US6026808||Jun 7, 1999||Feb 22, 2000||Sheffield Pharmaceuticals, Inc.||Methods and apparatus for delivering aerosolized medication|
|US6026809||Jan 25, 1996||Feb 22, 2000||Microdose Technologies, Inc.||Inhalation device|
|US6039042||Feb 23, 1998||Mar 21, 2000||Thayer Medical Corporation||Portable chamber for metered dose inhaler dispensers|
|US6044841||Aug 29, 1997||Apr 4, 2000||1263152 Ontario Inc.||Breath actuated nebulizer with valve assembly having a relief piston|
|US6085741||Apr 30, 1997||Jul 11, 2000||Pari Gmbh Spezialisten Fur Effektive Inhalation||Device for atomisation of fluids|
|US6089105||May 12, 1999||Jul 18, 2000||Cardiopulmonary Technologies, Inc.||Tubing connector|
|US6106479||Mar 31, 1998||Aug 22, 2000||Pari Gmbh Spezialisten Fur Effektive Inhalation||Breath simulator|
|US6557549 *||Apr 11, 2001||May 6, 2003||Trudell Medical International||Aerosol delivery apparatus with positive expiratory pressure capacity|
|US6581598 *||Nov 24, 1999||Jun 24, 2003||Dhd Healthcare Corporation||Positive expiratory pressure device|
|US6631721 *||Nov 3, 1999||Oct 14, 2003||Salter Labs||Nebulizer mouthpiece and accessories|
|1||"AARC Clinical Practice Guideline: Use of Positive Airway Pressure Adjuncts to Bronchial Hygiene Therapy", Respiratory Care, May 1993, vol. 38 No. 5, pp. 516-520.|
|2||"Technology Showcase Adjuncts to Bronchial Hygiene Therapy", AARC Times, May 1998, 2 pages.|
|3||Application as filed for U.S. Appl. No. 09/287,997, filed Apr. 7, 1999, 65 pages.|
|4||Application as filed for U.S. Appl. No. 09/287,997, filed Apr. 7, 1999.|
|5||Callahan, Thomas J., Ph.D., "K981944-BreatheRite," letter from Dept. of Health & Human Services, with enclosure, Aug. 24, 1998, 3 pages.|
|6||Claims as filed for U.S. Appl. No. 08/938,686, filed Sep. 26, 1997, 8 pages.|
|7||Claims as filed for U.S. application U.S. Appl. No. 09/938,686, filed Jun. 12, 2000.|
|8||E.F. Christensen et al., "Treatment of Bronchial Asthma with Terbutaline Inhaled by Conespacer Combined With Positive Expiratory Pressure Mask", Chest 100, vol. 2, 1991, pp. 317-321.|
|9||Hickey et al., Aerosol Generation from Propellant-Driven Metered Dose Inhalers, Title and Source Unknown, pp. 417-435.|
|10||International Search Report for PCT/IB 01/00599 dated Nov. 9, 2001, 8 pages.|
|11||International Search Report for PCT/IB01/00599 dated Nov. 9, 2001.|
|12||J.B. Andersen et al., "A new Mode of Administration of Nebulized Bronchodilator in Severe Bronchospasm", Eur J Respir Dis Suppl 119, vol. 63, 1982, pp. 97-100.|
|13||J.L. Rau et al., "Combining a Positive Expiratory Pressure Device with a Metered-Dose Inhaler Reservoir System Using Chlorofluorocarbon Albuterol and Hydrofluoroalkane Albuterol: Effect on Dose and Particle Size Distributions", Respiratory Care, Mar. 2000, vol. 45 No. 3, pp. 320-326.|
|14||J.L. Rau, Respiratory Care Pharmacology, 4th ed. (1994, Mosby), pp. 256-261.|
|15||K. Meeran et al., "Oral and Inhaled Corticosteroids Reduce Bone Formation as Shown by Plasma Osteocalcin Levels", American J. Respir. Crit. Care Med 151:333-336.|
|16||M.J. Mahlmeister et al., "Positive-Expiratory-Pressure Mask Therapy: Theoretical and Practical Considerations and a Review of the Literature", Respiratory Care Nov. 1991, vol. 36, No. 11, pp. 1218-1229.|
|17||Merriam-Webster's Collegiate Dictionary, Tenth Ed., p. 86, ISBN 0-87779-707-2, Sep. 1993.|
|18||Pamphlet for "PARI PEP System", Part No. 18F61, published prior to Apr. 11, 2001, 4 pages.|
|19||Pamphlet for "TheraPEP: Positive Expiratory Pressure Therapy System", Catalog No. 20-1112, published prior to Apr. 11, 2001, 4 pages.|
|20||Pamphlet for "TheraPEP:Positive Expiratory Pressure Therapy System", Catalog No. 20-1112, published prior to Apr. 11, 2001, 4 pages.|
|21||Photographs of Ventlab BreatheRite holding chamber, Dec. 2000, 3 pages.|
|22||R. Wilson, "Positive Expiratory Pressure Therapy: The Key to Effective, Low-Cost Removal of Bronchial Secretions", The Journal for Respiratory Care Practitioners, Mar. 1999, pp. 67-68.|
|23||Request for Inter Partes Reexamination of U.S. Patent No. 7,562,656 issued Jul. 21, 2009, dated Aug. 3, 2009, 121 pages.|
|24||Respironics© OptiChamber Advantage chart, date unknown, 2 pages.|
|25||S.P. Newman, Aerosol Deposition Consideration in Inhalation Therapy, Chest/88/2/Aug., 1985/ [Supplement], pp. 152s-160s.|
|26||Ventlab Corporation, "Ventlab BreatheRite," Web page from http://www.ventlab.com/mdi.htm, Dec. 15, 2000, 2 pages.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|USD735316||Mar 11, 2013||Jul 28, 2015||Fsc Laboratories, Inc.||Inhalation spacer|
|USRE45068 *||Feb 13, 2012||Aug 12, 2014||Trudell Medical International||Aerosol delivery apparatus|
|U.S. Classification||128/200.23, 128/203.15, 128/205.24|
|International Classification||B65D83/06, A61M11/00, B05D7/14, A63B23/18, A61M16/20, A62B9/02, A61M15/00|
|Cooperative Classification||A63B23/18, A61M15/0086, A61M15/0016, A63B2208/12, A61M16/208, A61M15/0018|
|European Classification||A63B23/18, A61M16/20B, A61M15/00K|